title: Optimizing biomarkers and endpoints in oral cancer chemoprevention trials.
abstract: Chemoprevention, defined as the use of natural, synthetic, or biologic compounds to halt, reverse, or prevent the initial phases of carcinogenesis or the progression of neoplastic cells to cancer, has produced successes, but progress has been slow. Notably, in the field of oral cancer prevention and despite extensive clinical investigations, a standard systemic therapy for patients with oral premalignant lesions is yet to be developed. In view of safety concerns surrounding the use of pharmaceuticals, the use of phytochemicals derived from the diet has been considered but has not yet translated into clinical success. The Bowman Birk Inhibitor (BBI) is a serine protease inhibitor isolated from soybeans possessing domains with trypsin and chymotrypsin inhibitory activity. Encouraging results were previously reported in a phase IIa trial of BBI complex in patients with oral leukoplakia with measurable clinical responses and favorable biomarker changes. In this issue of the journal, the less promising results of the randomized, placebo-controlled phase IIb trial are presented. In this commentary, the complexities involved in defining optimal biomarkers and endpoints for oral cancer prevention trials and the development of dietary chemoprevention agents are discussed.
authors: Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 432, Houston, TX 77030, USA.
authors: William N
authors: WN
authors: William
authors: Vassiliki A
authors: VA
authors: Papadimitrakopoulou
mesh_terms: D005260:Female; D006801:Humans; D007972:Leukoplakia, Oral / Q000188:drug therapy*; D008297:Male; D014358:Trypsin Inhibitor, Bowman-Birk Soybean / Q000627:therapeutic use*; D014361:Trypsin Inhibitors / Q000627:therapeutic use*
chemical_list: D014358:Trypsin Inhibitor, Bowman-Birk Soybean; D014361:Trypsin Inhibitors
references: Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):43-7
references: 10667462
references: Clin Cancer Res. 2000 Dec;6(12):4684-91
references: 11156220
references: Stat Med. 1989 Apr;8(4):431-40
references: 2727467
references: Cancer Prev Res (Phila). 2013 May;6(5):410-8
references: 23639862
references: Clin Cancer Res. 2006 Jun 15;12(12):3661-97
references: 16778094
references: J Oral Pathol Med. 1995 May;24(5):198-200
references: 7616457
references: Cancer. 1976 Oct;38(4):1790-5
references: 1033027
references: J Maxillofac Surg. 1977 Feb;5(1):69-75
references: 265354
references: Cancer Epidemiol Biomarkers Prev. 1999 Jul;8(7):601-8
references: 10428197
references: Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Aug;80(2):188-91
references: 7552884
references: J Oral Pathol. 1985 Oct;14(9):698-708
references: 3932623
references: Cancer Prev Res (Phila). 2009 Jul;2(7):611-6
references: 19584074
references: J Natl Cancer Inst. 1986 Mar;76(3):447-52
references: 3081747
references: Community Dent Oral Epidemiol. 1980;8(6):283-333
references: 6937277
references: Oral Oncol. 2003 Dec;39(8):770-80
references: 13679200
references: Clin Cancer Res. 2000 May;6(5):1702-10
references: 10815888
references: Curr Opin Oncol. 2012 May;24(3):205-10
references: 22273549
references: Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug;4(5):521-7
references: 7549809
references: Pharmacol Ther. 1998 Jun;78(3):167-209
references: 9690817
references: Oral Surg Oral Med Oral Pathol. 1972 Sep;34(3):426-33
references: 4505755
references: Cancer Prev Res (Phila). 2009 Jun;2(6):525-30
references: 19470784
references: J Oral Pathol. 1972;1(1):22-9
references: 4626992
references: Nutr Cancer. 1993;19(2):191-200
references: 8502589
references: Acad Med. 2001 Mar;76(3):238-47
references: 11242573
references: J Pathol. 1998 Apr;184(4):360-8
references: 9664901
references: Nat Rev Drug Discov. 2009 Mar;8(3):213-25
references: 19247304
references: Cancer Prev Res (Phila). 2011 Mar;4(3):347-53
references: 21372034
references: J Clin Oncol. 2009 Feb 1;27(4):599-604
references: 19075276
references: J Natl Cancer Inst. 1998 Oct 21;90(20):1545-51
references: 9790547